Immunohistochemical detection of oestrogen receptors in ductal carcinoma in situ of the breast
Data up to Jan 2025
Total Citations Per Year
Abstract
References (27)
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
1992 • 2,084 citations
A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors
1989 • 1,471 citations
Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.
1985 • 995 citations
Systemic Treatment of Early Breast Cancer by Hormonal, Cytotoxic, or Immune Therapy:133 Randomised Trials involoving 31 000 Recurrences and 24 000 Deaths Among 75 000 Women (Summary)
1993 • 967 citations
Lumpectomy Compared with Lumpectomy and Radiation Therapy for the Treatment of Intraductal Breast Cancer
1993 • 832 citations
Monoclonal antibodies as probes for estrogen receptor detection and characterization
1982 • 181 citations
Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity.
1994 • 147 citations
THE PREVENTION OF BREAST CANCER
1986 • 143 citations
Detection of Estrogen Receptors with Monoclonal Antibodies in Routinely Processed Formalin-Fixed Paraffin Sections of Breast Carcinoma: Use of DNase Pretreatment to Enhance Sensitivity of the Reaction
1987 • 111 citations
Estrogen receptor immunohistoohemistry in carcinoma in situ of the breast
1992 • 104 citations
Relationship of steroid receptor, cell kinetics, and clinical status in patients with breast cancer.
1981 • 94 citations
Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and dna flow cytometry
1990 • 88 citations
Histopathologic characterization of human breast cancer in correlation with estrogen receptor status.A comparison of immunocytochemical and biochemical analysis
1988 • 81 citations
IN-SITU BREAST CANCER: THE EORTC CONSENSUS MEETING
1989 • 74 citations
Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein
1993 • 72 citations
Oestrogen receptors in benign epithelial lesions and intraduct carcinomas of the breast: an immunohistological study
1989 • 70 citations
Heterogeneity in hormone receptor status in primary and metastatic breast cancer.
1985 • 65 citations
Potential Value of Hormone Receptor Assay in Carcinoma In Situ of Breast
1990 • 65 citations
Demonstration of estrogen receptors by monoclonal antibody in formalin-fixed breast tumors.
1988 • 63 citations
Methodology of immunohistological detection of oestrogen receptor in human breast carcinoma in formalin‐fixed, paraffin‐embedded tissue: a comparison with frozen section methodology
1993 • 60 citations
Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer
1992 • 55 citations
Use of monoclonal antibody for assessment of estrogen receptor content in fine-needle aspiration biopsy specimen from patients with breast cancer.
1989 • 51 citations
Oestrogen receptor analysis: correlation between enzyme immunoassay and immunohistochemical methods.
1992 • 47 citations
Distribution of estrogen receptor in ductal carcinoma in situ of the breast.
1993 • 35 citations
Assessment of oestrogen receptor content of breast carcinoma by immunohistochemical techniques on fixed and frozen tissue and by biochemical ligand binding assay.
1990 • 27 citations
Determination of oestrogen responsiveness of breast cancer by competitive reverse transcription-polymerase chain reaction
1995 • 17 citations
The influence of obesity and age at diagnosis on the estrogen receptor status of breast cancers.Perimenopausal predominance of estrogen receptor negative tumors
1988 • 11 citations